This compound is primarily used in pharmaceutical research and development, particularly in the synthesis of complex organic molecules. Its structure, featuring a Boc-protected amine and a tetrahydropyridopyrimidine core, makes it a valuable intermediate in the creation of drug candidates. It is often employed in the design and synthesis of small molecule inhibitors targeting specific enzymes or receptors, especially in the fields of oncology and neurology. The Boc group provides stability during synthetic processes, while the dimethylamino moiety can enhance the binding affinity of the final compound to biological targets. Researchers utilize this chemical to explore potential therapeutic agents, focusing on optimizing pharmacokinetics and pharmacodynamics. Its application is crucial in early-stage drug discovery, where it contributes to the development of novel treatments for various diseases.